Filing Details

Accession Number:
0001209191-19-013859
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-26 20:13:41
Reporting Period:
2019-02-22
Accepted Time:
2019-02-26 20:13:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1067586 J Randall Steward 12544 High Bluff Drive, Suite 200
San Diego CA 92130
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-22 39,103 $23.41 58,562 No 4 M Direct
Common Stock Disposition 2019-02-22 39,103 $67.50 19,459 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2019-02-22 39,103 $0.00 39,103 $23.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-05 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $67.5002 per share, with a range of $67.16 to $68.095. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  2. 19,552 shares vested on 02/05/2017; 9,776 shares vested on 02/25/2018; 9,775 shares vested on 02/05/2019.